Open access
Sep 2026
Use of systemic menopausal hormone therapy among French women: a descriptive nationwide study over the 2011 to 2024 period
After prolonged declining use, systemic MHT initiation increased modestly after 2022, and prescribing appeared broadly aligned with current recommendations favouring transdermal oestradiol combined with micronised progesterone, for relatively short durations.
A.-M. Vilcu, P. Goussault-Capmas, Y. Zhai et al.
· medRxiv · 0 citations